3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
7
Active not recruiting
6
Withdrawn
3
Terminated
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
51
Lung Neoplasms
40
Carcinoma, Non-Small-Cell Lung
28
Neoplasm Metastasis
25
Brain Neoplasms
23
Lymphoma, Large B-Cell, Diffuse
22
Pancreatic Neoplasms
21
Breast Neoplasms
20
Glioma
19
Squamous Cell Carcinoma of Head and Neck
18
Glioblastoma
17
Multiple Myeloma
16
Urinary Bladder Neoplasms
13
Colorectal Neoplasms
13
Carcinoma, Renal Cell
13
Mouth Neoplasms
12
Oropharyngeal Neoplasms
11
Lymphoma, Mantle-Cell
11
Carcinoma
11
Triple Negative Breast Neoplasms
10
Melanoma
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Laryngeal Neoplasms
10
Ovarian Neoplasms
9
Nasopharyngeal Carcinoma
8
Lymphoma, Follicular
8
Leukemia, Myeloid, Acute
8
Hypopharyngeal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, B-Cell
7
Interventions
lutetium Lu 177 dotatate
2
Temozolomide
2
ONC206
2
Etoposide
2
Cyclophosphamide
2
Bevacizumab
2
olaparib
1
neratinib
1
ibrutinib
1
fenofibric acid
1
etoposide phosphate
1
brigatinib
1
Watchful Waiting
1
Thalidomide
1
Restraint, Physical
1
Radiotherapy
1
Radiation
1
Magnetic Resonance Spectroscopy
1
Linear Energy Transfer
1
Irinotecan
1
Elasticity Imaging Techniques
1
Cytarabine
1
Celecoxib
1
Automobiles
1
1-methyltryptophan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ependymoma
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT04732065
2026-03-17
PNOC023
University of California, San Francisco
Phase 1
Recruiting
208 enrolled